You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 3, 2024

Investigational Drug Information for KW-6356


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for KW-6356?

KW-6356 is an investigational drug.

There have been 8 clinical trials for KW-6356. The most recent clinical trial was a Phase 2 trial, which was initiated on September 29th 2018.

The most common disease conditions in clinical trials are Parkinson Disease, Liver Diseases, and [disabled in preview]. The leading clinical trial sponsors are Kyowa Kirin Co., Ltd., Kyowa Hakko Kirin Co., Ltd, and Kyowa Kirin Pharmaceutical Development, Inc.

Recent Clinical Trials for KW-6356
TitleSponsorPhase
A Through QT/QTc Study of KW-6356Kyowa Kirin Co., Ltd.Phase 1
Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major MetaboliteKyowa Kirin Pharmaceutical Development, Inc.Phase 1
Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major MetaboliteKyowa Kirin, Inc.Phase 1

See all KW-6356 clinical trials

Clinical Trial Summary for KW-6356

Top disease conditions for KW-6356
Top clinical trial sponsors for KW-6356

See all KW-6356 clinical trials

International Patents for KW-6356

Drugname Country Document Number Estimated Expiration Related US Patent
KW-6356 Australia AU2010242375 2029-04-28 ⤷  Try a Trial
KW-6356 Brazil BRPI1011768 2029-04-28 ⤷  Try a Trial
KW-6356 Canada CA2760048 2029-04-28 ⤷  Try a Trial
KW-6356 Chile CL2011002650 2029-04-28 ⤷  Try a Trial
KW-6356 China CN102414209 2029-04-28 ⤷  Try a Trial
KW-6356 China CN104557904 2029-04-28 ⤷  Try a Trial
KW-6356 China CN104606190 2029-04-28 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.